AI ASSISTANT
Ask DrugCentral
Explore drug properties, targets, and indications with answers grounded in DrugCentral.
Powered by DrugCentral + retrieval-augmented AIYour question
Ask in your own words. Each question is answered independently.
Explore sample questions
Select a question to fill the editor, then ask it or make it your own.
DrugCentral answer
Your answer will appear here. Open linked drug cards in a new tab to explore the source details.
About Ask DrugCentral
Ask DrugCentral helps you explore drug properties, biological targets, and indications using natural language. Sample questions offer starting points, and linked drug cards let you check the underlying records.
General architecture
- Ask a questionThe browser sends your question to the same-origin Django chat API.
- Retrieve and generateThe API forwards the question to the configured DrugCentral retrieval-augmented generation (RAG) service, which returns an AI-generated answer.
- Explore the answerThe app resolves cited drug-card names and displays the answer with links to drug records.
Using the assistant
Each request is independent; previous questions are not sent as conversation history. You can edit a sample before submitting, retry a failed request, or switch back to normal search. Drug links open in a new tab so your question and answer stay available.
Answers may contain mistakes or omit information. Verify details against DrugCentral records and original sources.
AI can make mistakes. Verify answers against the original sources before relying on them.
oxytetracycline 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| antibiotics, protein-synthesis inhibitors, tetracycline derivatives | 2041 | 79-57-2 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
A TETRACYCLINE analog isolated from the actinomycete STREPTOMYCES RIMOSUS and used in a wide variety of clinical conditions.
Legend: OFP - off patent OFM - off market ONP - on patent |
Drug dosage:
| Dose | Unit | Route |
|---|---|---|
| 1 | g | O |
| 1 | g | P |
ADMET properties:
| Property | Value | Reference |
|---|---|---|
| MRTD (Maximum Recommended Therapeutic Daily Dose) | 72.32 µM/kg/day | Contrera JF, Matthews EJ, Kruhlak NL, Benz RD |
| BDDCS (Biopharmaceutical Drug Disposition Classification System) | 4 | Bocci G, Oprea TI, Benet LZ |
| BA (Bioavailability) | 58 % | Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H |
| Vd (Volume of distribution) | 1.70 L/kg | Lombardo F, Berellini G, Obach RS |
| CL (Clearance) | 2 mL/min/kg | Lombardo F, Berellini G, Obach RS |
| fu (Fraction unbound in plasma) | 0.90 % | Lombardo F, Berellini G, Obach RS |
| t_half (Half-life) | 10 hours | Lombardo F, Berellini G, Obach RS |
| S (Water solubility) | 0.20 mg/mL | Bocci G, Oprea TI, Benet LZ |
Predicted pharmacokinetic/toxicological properties (PK-AZ):
| Property | Description | Value | Unit | Confidence | Similarity |
|---|---|---|---|---|---|
| azlogd74 | LogD at pH 7.4 | -0.686 | High | 1 | |
| caco2-efflux | Caco-2 efflux ratio (BA/AB) | 1.542 | High | 1 | |
| caco2-intrinsic-papp | Caco-2 intrinsic apparent permeability | 0.847 | 10^-6 cm/s | High | 1 |
| dh-clint | Dog hepatocyte intrinsic clearance | 2.089 | uL/min/10^6 cells | High | 1 |
| dppb | Dog plasma protein binding (% unbound) | 52.530 | % | High | 1 |
| fcs-ppb | Fetal calf serum protein binding (% unbound) | 39.890 | % | High | 1 |
| herg | hERG pIC50 | 4.712 | pIC50 | High | 1 |
| hh-clint | Human hepatocyte intrinsic clearance | 2.023 | uL/min/10^6 cells | High | 1 |
| hlm-clint | Human liver microsomal intrinsic clearance | 3.289 | uL/min/mg protein | High | 1 |
| hppb | Human plasma protein binding (% unbound) | 52.590 | % | High | 1 |
| kinase-safety-class | ACVR2A,ACVR2B,ACVRL1,AKT2,AKT3,AURKA,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK2,CDK4,CDK5,CDK9,DDR1,DYRK1B,EGFR,EIF2AK3,EPHB4,ERBB2,FLT3,GRK2,GRK3,GSK3B,IKBKB,ITK,JAK1,JAK2,JAK3,KDR,KIT,MAP2K6,MAP3K14,MAP3K21,MAP3K3,MAP3K7,MAP4K1,MAPK10,MAPK7,MAPK8,MAPK9,MAPKAPK2,MAPKAPK5,MTOR,NTRK2,PDK1,PDK2,PIK3CA,PIK3CB,PIM2,PLK1,PLK2,PLK3,PLK4,PRKCD,PRKDC,SIK2,SIK3,STK33,SYK,TEK,TGFBR1,TTK | 64 | |||
| kinase-selectivity-class | ACVR2B,AXL,BRAF,CDK4,CDK9,EIF2AK3,EPHB4,GRK2,JAK2,MAP2K6,MAP3K14,MAP3K2,MAPK12,MAPK7,MAPK8,PRKDC,STK33,SYK,TEK,TGFBR1,ZAP70 | 21 | |||
| mdck-mdr1-bcrp-efflux | MDCK-MDR1-BCRP efflux ratio | 1.012 | High | 1 | |
| mdck-mdr1-efflux | MDCK-MDR1 efflux ratio | 3.811 | High | 1 | |
| mh-clint | Mouse hepatocyte intrinsic clearance | 5.957 | High | 1 | |
| mppb | Mouse plasma protein binding (% unbound) | 47.300 | High | 1 | |
| nih-mdck-mdr1-efflux | NIH MDCK-MDR1 efflux ratio | 4.036 | High | 1 | |
| pfas-class | PFAS structural alert (1 = True, 0 = False) | 0 | |||
| pld-class | Phospholipidosis risk class (1 = positive, 0 = negative) | 0 | Moderate | 0.68 | |
| pppb | Pig plasma protein binding (% unbound) | 48.960 | % | High | 1 |
| rat-kpuu-brain | Rat brain Kpuu | 0.009 | % | High | 1 |
| rh-clint | Rat hepatocyte intrinsic clearance | 1.318 | uL/min/10^6 cells | High | 1 |
| rh-fuinc | Rat hepatocyte fraction unbound in incubation | 82.590 | % | High | 1 |
| rppb | Rat plasma protein binding (% unbound) | 40.500 | % | High | 1 |
| solubility-dd | Solubility at pH 7.4 in DMSO | 909.913 | uM | High | 1 |
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Sept. 8, 1964 | FDA | PFIZER |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | A01AB25 | ALIMENTARY TRACT AND METABOLISM STOMATOLOGICAL PREPARATIONS STOMATOLOGICAL PREPARATIONS Antiinfectives and antiseptics for local oral treatment |
| ATC | D06AA03 | DERMATOLOGICALS ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE ANTIBIOTICS FOR TOPICAL USE Tetracycline and derivatives |
| ATC | G01AA07 | GENITO URINARY SYSTEM AND SEX HORMONES GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS Antibiotics |
| ATC | J01AA06 | ANTIINFECTIVES FOR SYSTEMIC USE ANTIBACTERIALS FOR SYSTEMIC USE TETRACYCLINES Tetracyclines |
| ATC | J01AA56 | ANTIINFECTIVES FOR SYSTEMIC USE ANTIBACTERIALS FOR SYSTEMIC USE TETRACYCLINES Tetracyclines |
| ATC | S01AA04 | SENSORY ORGANS OPHTHALMOLOGICALS ANTIINFECTIVES Antibiotics |
| FDA CS | M0021223 | Tetracyclines |
| FDA EPC | N0000175505 | Tetracycline-class Antimicrobial |
| MeSH PA | D000890 | Anti-Infective Agents |
| MeSH PA | D000900 | Anti-Bacterial Agents |
| CHEBI has role | CHEBI:33281 | antimicrobial agent |
| CHEBI has role | CHEBI:33282 | antibacterial agent |
| CHEBI has role | CHEBI:35441 | antiinfective agent |
| CHEBI has role | CHEBI:35472 | anti-inflammatory drug |
| CHEBI has role | CHEBI:36047 | antibacterial drug |
| CHEBI has role | CHEBI:48001 | protein synthesis inhibitor |
| CHEBI has role | CHEBI:66981 | ophthalmology drug |
| CHEBI has role | CHEBI:76969 | bacterial metabolite |
Related Drugs by ATC class:
A01AB Antiinfectives and antiseptics for local oral treatment 22 drugs
D06AA Tetracycline and derivatives 3 drugs
G01AA Antibiotics 10 drugs
J01AA Tetracyclines 13 drugs
S01AA Antibiotics 27 drugs
Drug Use | Suggest Off label Use Form| |View source of the data|
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Trachoma | indication | 2576002 | DOID:11265 |
| Actinomycotic infection | indication | 11817007 | DOID:8478 |
| Infection of skin AND/OR subcutaneous tissue | indication | 19824006 | |
| Gingivostomatitis | indication | 20607006 | |
| Acute gonococcal cervicitis | indication | 20943002 | DOID:10615 |
| Granuloma inguinale | indication | 28867007 | DOID:9113 |
| Acute gonococcal urethritis | indication | 29864006 | |
| Acute gonococcal epididymo-orchitis | indication | 30168008 | DOID:10802 |
| Bronchitis | indication | 32398004 | DOID:6132 |
| Sinusitis | indication | 36971009 | |
| Gonorrhea of rectum | indication | 42746002 | |
| Acute gonococcal endometritis | indication | 65295003 | DOID:7527 |
| Urinary tract infectious disease | indication | 68566005 | |
| Yaws | indication | 70647001 | DOID:10371 |
| Gonorrhea of pharynx | indication | 74372003 | |
| Rickettsialpox | indication | 75096007 | DOID:11103 |
| Ornithosis | indication | 75116005 | DOID:11262 |
| Brucellosis | indication | 75702008 | DOID:11077 |
| Syphilis | indication | 76272004 | |
| Bacterial conjunctivitis | indication | 128350005 | DOID:9700 |
| Rocky Mountain spotted fever | indication | 186772009 | |
| Q fever | indication | 186788009 | DOID:11100 |
| Lymphogranuloma venereum | indication | 186946009 | DOID:13819 |
| Pneumonia | indication | 233604007 | DOID:552 |
| Inclusion conjunctivitis | indication | 266109000 | |
| Infective otitis media | indication | 312218008 | |
| Bacterial keratitis | indication | 314557000 | |
| Pharyngitis | indication | 405737000 | DOID:2275 |
| Anthrax | indication | 409498004 | DOID:7427 |
| Relapsing fever | indication | 420079008 | DOID:13034 |
| Chlamydia trachomatis infection of genital structure | indication | 428015005 | |
| Rectal Chlamydia Trachomatis Infection | indication | ||
| Typhus Infections | indication | ||
| Superficial Ocular Infection | indication | ||
| Tularemia | off-label use | 19265001 | |
| Enterocolitis | off-label use | 43752006 | |
| Pneumonia due to Mycoplasma pneumoniae | off-label use | 46970008 | |
| Plague | off-label use | 58750007 | DOID:3482 |
| Cholangitis | off-label use | 82403002 | DOID:9446 |
| Chlamydial infection | off-label use | 105629000 | |
| Infectious disease of abdomen | off-label use | 128070006 | |
| Ocular rosacea | off-label use | 200933006 | |
| Complete atrioventricular block | contraindication | 27885002 | |
| Shock | contraindication | 27942005 | |
| Hypovolemia | contraindication | 28560003 | |
| Glomerulonephritis | contraindication | 36171008 | DOID:2921 |
| Acute hepatitis | contraindication | 37871000 | |
| Hypokalemia | contraindication | 43339004 | |
| Uremia | contraindication | 44730006 | DOID:4676 |
| Stokes-Adams syndrome | contraindication | 46935006 | |
| Chronic heart failure | contraindication | 48447003 | |
| Atrial fibrillation | contraindication | 49436004 | DOID:0060224 |
| Sinus bradycardia | contraindication | 49710005 | |
| Acute nephropathy | contraindication | 58574008 | |
| Wolff-Parkinson-White pattern | contraindication | 74390002 | DOID:384 |
| Decreased respiratory function | contraindication | 80954004 | |
| Kidney disease | contraindication | 90708001 | DOID:557 |
| Anemia due to enzyme deficiency | contraindication | 111577008 | |
| Deficiency of glucose-6-phosphate dehydrogenase | contraindication | 124134002 | DOID:2862 |
| Partial atrioventricular block | contraindication | 195039008 | |
| Disease of liver | contraindication | 235856003 | DOID:409 |
| Pregnancy, function | contraindication | 289908002 | |
| Hypoxia | contraindication | 389086002 | |
| Pseudomembranous enterocolitis | contraindication | 397683000 | |
| Breastfeeding (mother) | contraindication | 413712001 | |
| Reduced Hepatic Blood Flow | contraindication | ||
| Lidocaine Toxicity | contraindication |
🐶 Veterinary Drug Use
| Species | Use | Relation |
|---|---|---|
| Bees | American foulbrood caused by Paenibacillus larvae | Indication |
| Bees | European foulbrood caused by Streptococcus pluton | Indication |
| Cats | Bacterial pneumonia caused by Brucella bronchiseptica | Indication |
| Cats | Tonsillitis caused by Streptococcus hemolyticus | Indication |
| Cats | Bacterial enteritis caused by Escherichia coli | Indication |
| Cats | Urinary tract infections caused by Escherichia coli | Indication |
| Cats | Wound infections caused by Staphylococcus aureus | Indication |
| Cattle | Pneumonia and shipping fever complex associated with Pasteurella species | Indication |
| Cattle | Pneumonia and shipping fever complex associated with Actinobacillus pleuropneumoniae | Indication |
| Cattle | Pneumonia and shipping fever complex associated with Klebsiella species | Indication |
| Cattle | Foot-rot caused by Spherophorus necrophorus | Indication |
| Cattle | Diphtheria caused by Spherophorus necrophorus | Indication |
| Cattle | Bacterial enteritis caused by Salmonella typhimurium | Indication |
| Cattle | Bacterial enteritis caused by Escherichia coli | Indication |
| Cattle | Wooden tongue caused by Actinobacillus lignieresi | Indication |
| Cattle | Leptospirosis caused by Leptospira pomona | Indication |
| Cattle | Wound infections caused by staphylococcal and streptococcal organisms | Indication |
| Cattle | Acute metritis caused by staphylococcal and streptococcal organisms | Indication |
| Cattle | Reduction of the incidence of liver abscesses | Indication |
| Cattle | Anaplasmosis caused by Anaplasma marginale | Indication |
| Cattle | Anthrax caused by Bacillus anthracis | Indication |
| Cattle | Bovine keratoconjunctivitis (pinkeye) caused by Moraxella bovis | Indication |
| Chickens | Air sacculitis (air-sac disease chronic respiratory disease) caused by Mycoplasma gallisepticum | Indication |
| Chickens | Air sacculitis (air-sac disease chronic respiratory disease) caused by Escherichia coli | Indication |
| Chickens | Cholera caused by Pasteurella multocida | Indication |
| Chickens | Infectious sinusitis caused by Mycoplasma gallisepticum | Indication |
| Chickens | Infectious synovitis caused by Mycoplasma synoviae | Indication |
| Dogs | Bacterial pneumonia caused by Brucella bronchiseptica | Indication |
| Dogs | Tonsillitis caused by Streptococcus hemolyticus | Indication |
| Dogs | Bacterial enteritis caused by Escherichia coli | Indication |
| Dogs | Urinary tract infections caused by Staphylococcus species | Indication |
| Dogs | Urinary tract infections caused by Escherichia coli | Indication |
| Dogs | Wound infections caused by Staphylococcus aureus | Indication |
| Fish - Catfish | Bacterial hemorrhagic septicemia caused by Aeromonas hydrophila | Indication |
| Fish - Catfish | Pseudomonas disease | Indication |
| Fish - Finfish | Skeletal marking of finfish fry and fingerlings | Indication |
| Fish - Freshwater-reared Oncorhynchus mykiss | Columnaris disease associated with Flavobacterium columnare | Indication |
| Fish - Freshwater-reared Salmonids | Coldwater disease associated with Flavobacterium psychrophilum | Indication |
| Fish - Pacific Salmon | Marking of skeletal tissue | Indication |
| Fish - Salmonids | Ulcer disease caused by Haemophilus piscium | Indication |
| Fish - Salmonids | Furunculosis caused by Aeromonas salmonicida | Indication |
| Fish - Salmonids | Bacterial hemorrhagic septicemia caused by Aeromonas hydrophila | Indication |
| Fish - Salmonids | Pseudomonas disease | Indication |
| Horses | No Use Class Stated Or Implied | Indication |
| Lobsters | Gaffkemia caused by Aerococcus viridans | Indication |
| Sheep | Bacterial enteritis caused by Escherichia coli | Indication |
| Sheep | Bacterial pneumonia caused by Pasteurella multocida | Indication |
| Swine | Leptospirosis caused by Leptospira pomona | Indication |
| Swine | Bacterial enteritis caused by Escherichia coli | Indication |
| Swine | Bacterial enteritis caused by Escherichia coli | Indication |
| Swine | Bacterial pneumonia caused by Pasteurella multocida | Indication |
| Swine | Bacterial enteritis caused by Salmonella choleraesuis | Indication |
| Turkeys | Complicating bacterial organisms associated with bluecomb | Indication |
| Turkeys | Hexamitiasis caused by Hexamita meleagridis | Indication |
| Turkeys | Iinfectious synovitis caused by Mycoplasma synoviae | Indication |
| Turkeys | Air sacculitis (air-sac disease chronic respiratory disease) caused by Mycoplasma gallisepticum | Indication |
| Turkeys | Cholera caused by Pasteurella multocida | Indication |
| Turkeys | Infectious sinusitis caused by Mycoplasma gallisepticum | Indication |
| Turkeys | Air sacculitis (air-sac disease chronic respiratory disease) caused by Escherichia coli | Indication |
🐶 Veterinary products
| Product | Applicant | Ingredients |
|---|---|---|
| Terramycin Vet Capsules | Zoetis Inc. | 1 |
| TERRAMYCIN-343, TERRAMYCIN, TERRAMYCIN Soluble Powder Concentrate | Zoetis Inc. | 1 |
| Terramycin Ophthalmic Ointment with Polymyxin | Zoetis Inc. | 2 |
| Liquamycin Injectable, Terramycin Injectable | Zoetis Inc. | 1 |
| TM-50 , TM-50 D , TM-100 , TM-100D | Phibro Animal Health Corp. | 1 |
| Terramycin Scours Tablets | Zoetis Inc. | 1 |
| Liquamycin Intramuscular | Zoetis Inc. | 2 |
| Liqua-Cortril Spray, Terra-Cortril Spray | Zoetis Inc. | 2 |
| MAGNA-TERRAMYCIN Soluble Powder | Zoetis Inc. | 2 |
| OXY WS | Phibro Animal Health Corp. | 1 |
| Terramycin 100 for Fish, Terramycin 200 for Fish | Phibro Animal Health Corp. | 1 |
| Oxyject | Cronus Pharma Specialities India Private Limited | 1 |
| MGA (liquid) and TM | Zoetis Inc. | 2 |
| MGA and TM | Zoetis Inc. | 2 |
| Bio-Mycin, Oxy-Tet 50 | Cronus Pharma Specialities India Private Limited | 1 |
| Oxytetracycline-50 | Huvepharma EOOD | 1 |
| Aquachel 100 mg | Zoetis Inc. | 2 |
| Rachelle Oxyvet Injection | Zoetis Inc. | 1 |
| Liquamycin 100, Terramycin 100 | Zoetis Inc. | 1 |
| Neo-Terramycin 100/100, Neo-Terramycin 100/100D, Neo-Terramycin 50/50, Neo-Terramycin 50/50D | Phibro Animal Health Corp. | 2 |
| Terramycin 10, Terramycin 30, Terramycin 50, Terramycin 100, Terramycin 200, Terramycin 200 Granular, Terramycin 100MR | Phibro Animal Health Corp. | 1 |
| Bio-Mycin C, Oxy-Tet Injection | Boehringer lngelheim Animal Health USA Inc. | 1 |
| Oxyject 100 | Cronus Pharma Specialities India Private Limited | 1 |
| Coban/TM | Phibro Animal Health Corp. | 2 |
| Aquachel-100, Oxyvet-100 | Zoetis Inc. | 1 |
| TM plus Robenz | Phibro Animal Health Corp. | 2 |
| Medamycin Injectable | Cronus Pharma Specialities India Private Limited | 1 |
| Liquamycin LA-200, Liquamycin LA-200 (Rx) | Zoetis Inc. | 1 |
| Compudose 200, Encore (Compudose 400 ) | Elanco US Inc. | 2 |
| OXYMarine, Oxytet Soluble | Huvepharma EOOD | 1 |
| Pennox 50, Pennox 100-MR, Pennox 100 Hi-Flo, Pennox 200 Hi-Flo | Pharmgate Inc. | 1 |
| Neo-Oxy 100/100 MR, Neo-Oxy 50/50 | Pharmgate Inc. | 2 |
| TM plus Bio-Cox | Phibro Animal Health Corp. | 2 |
| BOVATEC and TM | Zoetis Inc. | 2 |
| Oxytetracycline Hydrochloride Injection | Bimeda Animal Health Limited | 1 |
| OXY 1000 Calf Bolus, OXY 500 Calf Bolus | Boehringer lngelheim Animal Health USA Inc. | 1 |
| Noromycin 300 LA, TETRADURE 300 | Norbrook Laboratories, Ltd. | 1 |
| Mecadox and Terramycin | Phibro Animal Health Corp. | 2 |
| Hexasol Injection | Norbrook Laboratories, Ltd. | 2 |
| Bio-Mycin 200 , Oxy-Tet 200 Injectable Solution | Boehringer lngelheim Animal Health USA Inc. | 1 |
| Pennox 343 | Pharmgate Inc. | 1 |
| AGRIMYCIN-343 | Huvepharma EOOD | 1 |
| Oxytetracycline Hydrochloride Injection | Huvepharma EOOD | 1 |
| Sacox / Terramycin | Huvepharma EOOD | 2 |
| Oxytetracycline Injection, Oxytetracycline Injection | Bimeda Animal Health Limited | 1 |
| Maxim-200 Injection, Oxytetracycline Hydrochloride Injection 200mg | Huvepharma EOOD | 1 |
| Agrimycin - 200 | Huvepharma EOOD | 1 |
| Tetroxy HCA-280, Tetroxy HCA-1772, Tetroxy HCA-1400 | Bimeda Animal Health Limited | 1 |
| Tetroxy 25 | Bimeda Animal Health Limited | 1 |
| Oxytetracycline 200, Pennox 200 | Pharmgate Inc. | 1 |
| Tetroxy 343 | Bimeda Animal Health Limited | 1 |
| Oxytetracycline Injection 200 | Norbrook Laboratories, Ltd. | 1 |
| Oxytet 100 | Norbrook Laboratories, Ltd. | 1 |
| Tetroxy Aquatic | Bimeda Animal Health Limited | 1 |
| Tetroxy-LA | Bimeda Animal Health Limited | 1 |
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 3.29 | acidic |
| pKa2 | 7.19 | acidic |
| pKa3 | 9.79 | acidic |
| pKa4 | 11.29 | acidic |
| pKa5 | 12.0 | acidic |
| pKa6 | 12.56 | acidic |
| pKa7 | 13.24 | acidic |
| pKa8 | 9.06 | Basic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| 30S ribosomal protein S4 | Ribosomal protein | WOMBAT-PK | |||||||
| 30S ribosomal protein S9 | Ribosomal protein | WOMBAT-PK |
External reference:
| ID | Source |
|---|---|
| 4018624 | VUID |
| N0000146937 | NUI |
| D00205 | KEGG_DRUG |
| 6153-64-6 | SECONDARY_CAS_RN |
| 4018623 | VANDF |
| 4018624 | VANDF |
| 4018625 | VANDF |
| C0030092 | UMLSCUI |
| CHEBI:133011 | CHEBI |
| OTC | PDB_CHEM_ID |
| CHEMBL1517 | ChEMBL_ID |
| CHEMBL3989568 | ChEMBL_ID |
| CHEMBL1607480 | ChEMBL_ID |
| D010118 | MESH_DESCRIPTOR_UI |
| DB00595 | DRUGBANK_ID |
| 10919 | IUPHAR_LIGAND_ID |
| 13303-91-8 | SECONDARY_CAS_RN |
| 2058-46-0 | SECONDARY_CAS_RN |
| X20I9EN955 | UNII |
| 54675779 | PUBCHEM_CID |
| 1545999 | RXNORM |
| 2370 | MMSL |
| 33508 | MMSL |
| 5221 | MMSL |
| 5222 | MMSL |
| d01070 | MMSL |
| 002742 | NDDF |
| 002743 | NDDF |
| 002744 | NDDF |
| 1269152006 | SNOMEDCT_US |
| 22969001 | SNOMEDCT_US |
| 372675006 | SNOMEDCT_US |
| 395819008 | SNOMEDCT_US |
| 442345001 | SNOMEDCT_US |
| 54729007 | SNOMEDCT_US |
| 103 | INN_ID |
Pharmaceutical products:
None